148 related articles for article (PubMed ID: 17579384)
21. 2-acylamino-4,6-diphenylpyridine derivatives as novel GPR54 antagonists with good brain exposure and in vivo efficacy for plasma LH level in male rats.
Kobayashi T; Sasaki S; Tomita N; Fukui S; Nakayama M; Kiba A; Kusaka M; Matsumoto S; Yamaguchi M; Itoh F; Baba A
Bioorg Med Chem; 2010 Jul; 18(14):5157-71. PubMed ID: 20580563
[TBL] [Abstract][Full Text] [Related]
22. Novel and potent small-molecule urotensin II receptor agonists.
Lehmann F; Currier EA; Clemons B; Hansen LK; Olsson R; Hacksell U; Luthman K
Bioorg Med Chem; 2009 Jul; 17(13):4657-65. PubMed ID: 19481466
[TBL] [Abstract][Full Text] [Related]
23. The GPR54-Kisspeptin complex in reproductive biology: neuroendocrine significance and implications for ovulation induction and contraception.
Sills ES; Walsh AP
Neuro Endocrinol Lett; 2008 Dec; 29(6):846-51. PubMed ID: 19112386
[TBL] [Abstract][Full Text] [Related]
24. Structure-activity relationship of linear tetrapeptides Tic-DPhe-Arg-Trp-NH2 at the human melanocortin-4 receptor and effects on feeding behaviors in rat.
Ye Z; MacNeil T; Weinberg DH; Kalyani RN; Tang R; Strack AM; Murphy BA; Mosley RT; Euan MacIntyre D; Van der Ploeg LH; Patchett AA; Wyvratt MJ; Nargund RP
Peptides; 2005 Oct; 26(10):2017-25. PubMed ID: 15993513
[TBL] [Abstract][Full Text] [Related]
25. Isochromanone-based urotensin-II receptor agonists.
Lehmann F; Currier EA; Olsson R; Hacksell U; Luthman K
Bioorg Med Chem; 2005 Apr; 13(8):3057-68. PubMed ID: 15781415
[TBL] [Abstract][Full Text] [Related]
26. Biostable agonists that match or exceed activity of native insect kinins on recombinant arthropod GPCRs.
Taneja-Bageshwar S; Strey A; Isaac RE; Coast GM; Zubrzak P; Pietrantonio PV; Nachman RJ
Gen Comp Endocrinol; 2009 May; 162(1):122-8. PubMed ID: 18983996
[TBL] [Abstract][Full Text] [Related]
27. New insight into the binding mode of peptide ligands at Urotensin-II receptor: structure-activity relationships study on P5U and urantide.
Grieco P; Carotenuto A; Campiglia P; Gomez-Monterrey I; Auriemma L; Sala M; Marcozzi C; d'Emmanuele di Villa Bianca R; Brancaccio D; Rovero P; Santicioli P; Meini S; Maggi CA; Novellino E
J Med Chem; 2009 Jul; 52(13):3927-40. PubMed ID: 19432421
[TBL] [Abstract][Full Text] [Related]
28. The discovery of 3-(N-alkyl)aminopropylphosphonic acids as potent S1P receptor agonists.
Hale JJ; Doherty G; Toth L; Li Z; Mills SG; Hajdu R; Ann Keohane C; Rosenbach M; Milligan J; Shei GJ; Chrebet G; Bergstrom J; Card D; Rosen H; Mandala S
Bioorg Med Chem Lett; 2004 Jul; 14(13):3495-9. PubMed ID: 15177460
[TBL] [Abstract][Full Text] [Related]
29. New bradykinin analogues acylated on the N-terminus: effect on rat uterus and blood pressure.
Labudda O; Wierzba T; Sobolewski D; Sleszyńska M; Gawiński Ł; Plackova M; Slaninová J; Prahl A
Acta Biochim Pol; 2007; 54(1):193-8. PubMed ID: 17220954
[TBL] [Abstract][Full Text] [Related]
30. Molecular and conformational determinants of pituitary adenylate cyclase-activating polypeptide (PACAP) for activation of the PAC1 receptor.
Bourgault S; Vaudry D; Ségalas-Milazzo I; Guilhaudis L; Couvineau A; Laburthe M; Vaudry H; Fournier A
J Med Chem; 2009 May; 52(10):3308-16. PubMed ID: 19413310
[TBL] [Abstract][Full Text] [Related]
31. Structure-activity relationship studies of a new series of imidazo[2,1-f]purinones as potent and selective A(3) adenosine receptor antagonists.
Baraldi PG; Preti D; Tabrizi MA; Romagnoli R; Saponaro G; Baraldi S; Botta M; Bernardini C; Tafi A; Tuccinardi T; Martinelli A; Varani K; Borea PA
Bioorg Med Chem; 2008 Dec; 16(24):10281-94. PubMed ID: 19006671
[TBL] [Abstract][Full Text] [Related]
32. Hepta and octapeptide agonists of protease-activated receptor 2.
Devlin MG; Pfeiffer B; Flanagan B; Beyer RL; Cocks TM; Fairlie DP
J Pept Sci; 2007 Dec; 13(12):856-61. PubMed ID: 17890655
[TBL] [Abstract][Full Text] [Related]
33. 3-Nitro-4-amino benzoic acids and 6-amino nicotinic acids are highly selective agonists of GPR109b.
Skinner PJ; Cherrier MC; Webb PJ; Sage CR; Dang HT; Pride CC; Chen R; Tamura SY; Richman JG; Connolly DT; Semple G
Bioorg Med Chem Lett; 2007 Dec; 17(23):6619-22. PubMed ID: 17931863
[TBL] [Abstract][Full Text] [Related]
34. Nongenomic actions of bile acids. Synthesis and preliminary characterization of 23- and 6,23-alkyl-substituted bile acid derivatives as selective modulators for the G-protein coupled receptor TGR5.
Pellicciari R; Sato H; Gioiello A; Costantino G; Macchiarulo A; Sadeghpour BM; Giorgi G; Schoonjans K; Auwerx J
J Med Chem; 2007 Sep; 50(18):4265-8. PubMed ID: 17685603
[TBL] [Abstract][Full Text] [Related]
35. Novel potent and efficacious nonpeptidic urotensin II receptor agonists.
Lehmann F; Pettersen A; Currier EA; Sherbukhin V; Olsson R; Hacksell U; Luthman K
J Med Chem; 2006 Apr; 49(7):2232-40. PubMed ID: 16570919
[TBL] [Abstract][Full Text] [Related]
36. G protein-coupled receptors of the hypothalamic-pituitary-gonadal axis: a case for Gnrh, LH, FSH, and GPR54 receptor ligands.
Heitman LH; Ijzerman AP
Med Res Rev; 2008 Nov; 28(6):975-1011. PubMed ID: 18561294
[TBL] [Abstract][Full Text] [Related]
37. Molecular field analysis and 3D-quantitative structure-activity relationship study (MFA 3D-QSAR) unveil novel features of bile acid recognition at TGR5.
Macchiarulo A; Gioiello A; Thomas C; Massarotti A; Nuti R; Rosatelli E; Sabbatini P; Schoonjans K; Auwerx J; Pellicciari R
J Chem Inf Model; 2008 Sep; 48(9):1792-801. PubMed ID: 18698841
[TBL] [Abstract][Full Text] [Related]
38. Design of selective peptidomimetic agonists for the human orphan receptor BRS-3.
Weber D; Berger C; Eickelmann P; Antel J; Kessler H
J Med Chem; 2003 May; 46(10):1918-30. PubMed ID: 12723954
[TBL] [Abstract][Full Text] [Related]
39. Essential role of TM V and VI for binding the C-terminal sequences of Des-Arg-kinins.
Santos EL; de Picoli Souza K; Cibrián-Uhalte E; Oliveira SM; Bader M; Costa-Neto CM; Oliveira L; Pesquero JB
Int Immunopharmacol; 2008 Feb; 8(2):282-8. PubMed ID: 18182241
[TBL] [Abstract][Full Text] [Related]
40. Discovery and optimization of a novel series of N-arylamide oxadiazoles as potent, highly selective and orally bioavailable cannabinoid receptor 2 (CB2) agonists.
Cheng Y; Albrecht BK; Brown J; Buchanan JL; Buckner WH; DiMauro EF; Emkey R; Fremeau RT; Harmange JC; Hoffman BJ; Huang L; Huang M; Lee JH; Lin FF; Martin MW; Nguyen HQ; Patel VF; Tomlinson SA; White RD; Xia X; Hitchcock SA
J Med Chem; 2008 Aug; 51(16):5019-34. PubMed ID: 18680277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
